関連する実験動画
Updated: Sep 9, 2025

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.0K
ビクテグラビル/エムトリチタビン/テノフォビルアラフェナミドへの抑制された切り替えと,ドゥルテグラビル/ラミヴジンとの比較:OPERAコホートからの実用的な証拠
Gerald Pierone1, Laurence Brunet2, Jennifer S Fusco2
1Whole Family Health Center, Vero Beach, Florida, USA.
HIV medicine
|August 30, 2025
まとめ
ビクテグラビル/エムトリチタビン/テノフォビルアラフェナミド (B/F/TAF) とドゥルテグラビル/ラミヴジン (DTG/3TC) はHIV治療に有効である. DTG / 3TCは,米国の臨床ケア研究で,B / F / TAFよりも早く中止する傾向を示しました.
科学分野:
- 感染症
- ウイルス学
- 薬理学について
背景:
- 抗レトロウイルス治療 (ART) はHIVの管理に不可欠です.
- 固定用量の組み合わせは,ウイルス学的に抑制された個体に対する治療を簡素化します.
- 患者のケアを最適化するために,異なるART療法の有効性と耐性を比較することが不可欠です.
研究 の 目的:
- ビクテグラビル/エムトリチタビン/テノフォビルアラフェナミド (B/F/TAF) とドゥルテグラビル/ラミヴジン (DTG/3TC) のウイルス学的有効性を比較する.
- ウイルス学的に抑制されたHIV患者におけるB/ F/ TAFおよびDTG/3TCの投与中止率を評価する.
- 米国における通常の臨床診療においてこれらの治療法を評価する.
主な方法:
- ウイルス学的に抑制されたART経験のある成人を含むOPERAコホートの分析.
- 2020年8月から2022年6月の間にB/F/TAFまたはDTG/3TCに移行した患者の比較.
- 確認されたウイルス学的失敗 (cVF200) と中止までの時間を評価するために,治療の重み付けの逆の確率を持つコックス比例の危険モデルを使用します.
主要な成果:
- B/ F/ TAF (2%) とDTG/3TC (3%) のグループでは,確認されたウイルス性欠損 (cVF200) の有意な差異はありません (aHR: 0. 84; 95% CI: 0. 59, 1. 18).
- DTG/3TC (19%) と比較して,B/ F/ TAFで治療中止率が低かった (aHR: 0. 83; 95% CI: 0. 73, 0. 94).
- B/ F/ TAFでは,DTG/3TC (9%) よりも治療中止率が低い.
結論:
- B/F/TAFとDTG/3TCは,ウイルス学的に抑制された個体にとって,耐受性があり有効なHIV治療の選択肢です.
- DTG/ 3TCは,このコホートにおけるB/ F/ TAFと比較して,より迅速な中止の傾向を示した.
- これらの発見は,HIV管理のための通常の臨床実践における両方の治療法の使用を支持します.
関連する概念動画
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Subviral Agents
111
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

